Quanterix (QTRX) FCF Margin Growth (1y) (2018 - 2026)
Quanterix (QTRX) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 261.00 |
| 10 | Quanterix | 159.26 Mn | 59.99 Mn | 15.57 Mn | -4.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.00 |
| Dec 31, 2025 | -2,942.00 |
| Sep 30, 2025 | -8,569.00 |
| Jun 30, 2025 | -723.00 |
| Mar 31, 2025 | 1,453.00 |
| Dec 31, 2024 | 1,829.00 |
| Sep 30, 2024 | -310.00 |
| Jun 30, 2024 | -1,981.00 |
| Mar 31, 2024 | -2,942.00 |
| Dec 31, 2023 | -5,417.00 |
| Sep 30, 2023 | 6,011.00 |
| Jun 30, 2023 | 5,594.00 |
| Mar 31, 2023 | 4,309.00 |
| Dec 31, 2022 | 1,931.00 |
| Sep 30, 2022 | -579.00 |
| Jun 30, 2022 | 1,186.00 |
| Mar 31, 2022 | -2,606.00 |
| Dec 31, 2021 | -108.00 |
| Sep 30, 2021 | -4,313.00 |
| Jun 30, 2021 | -93.00 |